These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7656786)

  • 1. [Management of intestinal obstruction in advanced ovarian cancer an analysis of 57 cases].
    Sun X; Li X; Li H
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):39-42. PubMed ID: 7656786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction.
    Abu-Rustum NR; Barakat RR; Venkatraman E; Spriggs D
    Gynecol Oncol; 1997 Mar; 64(3):493-5. PubMed ID: 9062158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin.
    van Ooijen B; van der Burg ME; Planting AS; Siersema PD; Wiggers T
    Surg Gynecol Obstet; 1993 May; 176(5):469-74. PubMed ID: 8480270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival following intestinal obstruction in ovarian cancer.
    Redman CW; Shafi MI; Ambrose S; Lawton FG; Blackledge GR; Luesley DM; Fielding JW; Chan KK
    Eur J Surg Oncol; 1988 Oct; 14(5):383-6. PubMed ID: 3181441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy.
    Lund B; Hansen M; Lundvall F; Nielsen NC; Sørensen BL; Hansen HH
    Surg Gynecol Obstet; 1989 Sep; 169(3):213-8. PubMed ID: 2475912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of bowel obstruction in advanced ovarian carcinoma.
    Krebs HB; Goplerud DR
    Obstet Gynecol; 1983 Mar; 61(3):327-30. PubMed ID: 6823374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
    Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
    Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
    Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
    Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative surgery for recurrent bowel obstruction due to advanced ovarian cancer.
    Caprotti R; Bonardi C; Crippa S; Mussi C; Angelini C; Uggeri F
    Minerva Ginecol; 2006 Jun; 58(3):239-44. PubMed ID: 16783296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of symptoms in terminally ill patients with ovarian carcinoma].
    Sun XG; Wu M; Ma SQ; Li CY; Jin LN; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):192-5. PubMed ID: 17537307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.
    Brard L; Weitzen S; Strubel-Lagan SL; Swamy N; Gordinier ME; Moore RG; Granai CO
    Gynecol Oncol; 2006 Oct; 103(1):176-80. PubMed ID: 16564074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benefit of palliative surgery for bowel obstruction in recurrent ovarian carcinoma].
    Li ZT; Wu XH; Fu SL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):260-3. PubMed ID: 15130355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer.
    Jong P; Sturgeon J; Jamieson CG
    Can J Surg; 1995 Oct; 38(5):454-7. PubMed ID: 7553472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate postlaparotomy small bowel obstruction: a 16-year retrospective analysis.
    Fraser SA; Shrier I; Miller G; Gordon PH
    Am Surg; 2002 Sep; 68(9):780-2. PubMed ID: 12356149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
    Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
    Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.